2Kobayashi S.Characterization of drugs for treating glaucoma whichare prostaglandin analogs with a stem name of "-Proston " or"-prost"[J]. J Med Association of Nippon Med Sch,2012,8(2):134-142. 被引量：1
3Takagi Y,Nakajima T,Shimazaki A,et al.Pharmacologicalcharacteristics of AFP-168(tafluprost),a new prostanoid FPreceptor agonist,as an ocular hypotensive drug[J].Exp Eye Res,2004,78(4);767-776. 被引量：1
5Kuwayama Y,Komemushi S.Phase III Confirmatory Study of0.0015% DE085(Tafluprost)Ophthalmic Solution as Comparedto 0.005% Latanoprost Ophthalmic Solution in Patients withOpen-Angle Glaucoma or Ocular Hypertension[J].AtarashiiGanka(Journal of the eye),2008,25(11):1595-1602. 被引量：1
6Neil T Choplin,Diane C Lundy[M].Atlas of Glaucoma,ed I.UK:Martin Dunitz Ltd,1998:39-55. 被引量：1
7European Glaucoma Society.Terminology and Guidelines forGlaucoma.3rd Edition[M].Savona,Italy:Editrice DOGMA,s.r.1.2008:118. 被引量：1
8Hellberg MR,Sallee VL,Mclaughlin MA,et al.PreclinicalEfficacy of Travoprost,a Potent and Selective FP Prostaglandin Receptor Agonist[J].J Ocular Pharmacol Therap,2001,17(5):421432. 被引量：1
9Sharif NA,Kelly CR,Crider JY,et al.Ocular hypotensive FPprostaglandin(PG)analogs:PG receptor subtype binding affinitiesand selectivities,and agonist potencies at FP and other PGreceptors in cultured cells[J].J Ocul Pharmacol Th,2003,19(6):501-515. 被引量：1
10American Academy of Ophthalmology.Preferred Practice Pattern:Primary Open-Angle Glaucoma[M].San Francisco,CA:American Academy of Ophthalmology,2010. 被引量：1
